The National Service Framework on coronary heart disease: is it sufficiently evidence-based?

Ann Clin Biochem. 2001 May;38(Pt 3):159-61. doi: 10.1258/0004563011900452.

Author

G A Ferns¹

Affiliation

¹ Centre for Clinical Science and Measurement, School of Biomedical anld Life Science, University of Surrey, Guildford, UK. g.ferns@surrey.ac.uk

PMID: 11392491
DOI: 10.1258/0004563011900452

No abstract available

MeSH terms

Anticholesteremic Agents / therapeutic use
Coronary Disease / diagnosis*
Coronary Disease / prevention & control*
Coronary Disease / therapy*
Delivery of Health Care / economics*
Delivery of Health Care / standards*
Evidence-Based Medicine
Humans
Lovastatin / therapeutic use
Phenotype
United Kingdom

Substances

Anticholesteremic Agents
Lovastatin